Thus, modulation of the PGE2–Ptger4 axis may help reestablish the immune balance between type I interferon (IFN-I) and IL-1 pathways, providing a novel direction for therapeutic intervention in type 1 diabetes mellitus (T1DM) (62). The gene discussed is IL1B; the disease is type 1 diabetes mellitus.